Loading company…
SpecificiT Pharma develops personalized cell-based cancer immunotherapies for blood cancers, based in Montreal, Canada.
SpecificiT Pharma Inc. is headquartered in Montreal, Canada and develops personalized cancer immunotherapies, mainly cellular therapies for hematological cancers that are not effectively treated by CAR-T therapies. Its approach uses Minor Histocompatibility Antigens (MiHAs) to direct donor T cells against cancer cells. It raised seed funding in September 2017 with participation from Accel-Rx Health Sciences Accelerator, Sanderling Ventures and returning investor GeneChem.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in